Ruth Matthew R.
- SEC CIK
- 0001872022
No open-market purchases or sales filed in the past year.
Current role at each company
- OPNT Opiant Pharmaceuticals, Inc.Chief Commercial Officeras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ruth Matthew R. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 (view filing) | Aug 31 | 1 day | Ruth Matthew R.Chief Commercial Officer | PPurchase | +2.00K | $17.34 | +$34.7K | +13.3%17.0K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Ruth Matthew R.Chief Commercial Officer | SSale | −1.08K | $10.62 | −$11.5K | −3.5%29.9K after |